Press Release Contact
Press release:
X4 Pharmaceuticals Announces Strategic Restructuring to Drive Value and Maximize Opportunity for Mavorixafor in Chronic Neutropenia
February 06, 2025, 12:35 GMT
For questions about this press release, please contact the person or organization listed below.